Intratumoural hypoxia can produce several different effects on cancer cells, ranging from metabolic reprogramming towards a glycolitic phenotype, over-expression of ABC transporters, selection of mutated cells whose apoptotic process is deficient, or protection from apoptotic inducers. Here, ABCG2 is linked to cancer.